Browsing publications by Professor Olaf Heidenreich

Newcastle AuthorsTitleYear
Dr Britta Vormoor
Henrike Knizia
Michael Batey
Dr Ian Wilson
Dr Petra Dildey
et al.
Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging2014
Dr Alex Elder
Dr Simon Bomken
Dr Helen Blair
Professor Josef Vormoor
Professor Olaf Heidenreich
et al.
Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia2014
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Dr Daniel Williamson
Dr Julie Irving
et al.
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations2013
Marta Omedes Pujol
Dan Coleman
Professor Olaf Heidenreich
Dr David Fulton
Determination of key structure-activity relationships in siRNA delivery with a mixed micelle system2013
Dr Simon Bomken
Dr Lars Buechler
Dr Klaus Rehe
Dr Frida Ponthan
Dr Alex Elder
et al.
Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression2013
Professor Olaf Heidenreich
Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression2013
Dr Andrea Beyerle
Hesta McNeill
Professor Olaf Heidenreich
Molecular Parameters of siRNA–Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery2013
Dr Frederik van Delft
Professor Olaf Heidenreich
Professor Bryan Young
AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia2012
Dr Andrea Beyerle
Professor Olaf Heidenreich
Dr James Allan
AML1/ETO Confers a Mutator Phenotype in AML2012
Professor Olaf Heidenreich
Depletion of RUNX1/ETO in t(8:21) AML cells leads to genome-wide changes in transcription factor binding2012
1234567891011